Cholangiocarcinoma

被引:1103
作者
Khan, SA
Thomas, HC
Davidson, BR
Taylor-Robinson, SD
机构
[1] Univ London Imperial Coll Sci Technol & Med, Fac Med, Div Med, Liver Unit, London, England
[2] Royal Free Hosp, Dept Surg, London NW3 2QG, England
关键词
D O I
10.1016/S0140-6736(05)67530-7
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Cholangiocarcinoma is a devastating malignancy that presents late, is notoriously difficult to diagnose, and is associated with a high mortality. The incidence of intrahepatic cholangiocarcinoma is increasing worldwide. The cause for this rise is unclear, although it could be related to an interplay between predisposing genetic factors and environmental triggers. MRI and CT with endoscopic ultrasound and PET provide useful diagnostic information in certain patients. Surgical resection is the only chance for cure, with results depending on careful technique and patient selection. Data suggest that liver transplantation could offer long-term survival in selected patients when combined with neoadjuvant chemoradiotherapy. Chemotherapy and radiotherapy have been ineffective for patients with inoperable tumours. For most of these patients biliary drainage is the mainstay of palliation. However, controversy exists over the type and positioning of biliary stents. Photodynamic treatment is a new palliative technique that might improve quality of life.
引用
收藏
页码:1303 / 1314
页数:12
相关论文
共 129 条
  • [71] Magnetic resonance imaging of cholangiocarcinoma
    Manfredi, R
    Barbaro, B
    Masselli, G
    Vecchioli, A
    Marano, P
    [J]. SEMINARS IN LIVER DISEASE, 2004, 24 (02) : 155 - 164
  • [72] Meier Y, 2004, HEPATOLOGY, V40, p471A
  • [73] Meyer CG, 2000, TRANSPLANTATION, V69, P1633
  • [74] Cholangiocarcinoma - A spectrum of intrahepatic, perihilar, and distal tumors
    Nakeeb, A
    Pitt, HA
    Sohn, TA
    Coleman, J
    Abrams, RA
    Piantadosi, S
    Hruban, RH
    Lillemoe, KD
    Yeo, CJ
    Cameron, JL
    [J]. ANNALS OF SURGERY, 1996, 224 (04) : 463 - 473
  • [75] Improved survival in resected biliary malignancies
    Nakeeb, A
    Tran, KQ
    Black, MJ
    Erickson, BA
    Ritch, PS
    Quebbeman, EJ
    Wilson, SD
    Demeure, MJ
    Rilling, WS
    Dua, KS
    Pitt, HA
    [J]. SURGERY, 2002, 132 (04) : 555 - 563
  • [76] Serum and bile markers for cholangiocarcinoma
    Nehls, O
    Gregor, M
    Klump, B
    [J]. SEMINARS IN LIVER DISEASE, 2004, 24 (02) : 139 - 154
  • [77] Oxaliplatin, fluorouracil and leucovorin for advanced biliary system adenocarcinomas: a prospective phase II trial
    Nehls, O
    Klump, B
    Arkenau, HT
    Hass, HG
    Greschniok, A
    Gregor, M
    Porschen, R
    [J]. BRITISH JOURNAL OF CANCER, 2002, 87 (07) : 702 - 704
  • [78] HEPATIC SEGMENTECTOMY WITH CAUDATE LOBE RESECTION FOR BILE-DUCT CARCINOMA OF THE HEPATIC HILUS
    NIMURA, Y
    HAYAKAWA, N
    KAMIYA, J
    KONDO, S
    SHIONOYA, S
    [J]. WORLD JOURNAL OF SURGERY, 1990, 14 (04) : 535 - 544
  • [79] Nimura Y, 2000, J Hepatobiliary Pancreat Surg, V7, P155, DOI 10.1007/s005340050170
  • [80] OHNISHI H, 1995, HEPATO-GASTROENTEROL, V42, P265